CD8A and myeloid sarcoma: When investigating levels of specific immune cell-derived EV subsets, while we did not measure any differences in total plasma EV size (Fig. 4C), a cross-sectional analysis demonstrated that levels of CD4+ and CD8+ EVs were significantly increased in the plasma of active MS patients compared to clinically stable (Fig. 4D).